Qualigen Therapeutics Appoints Amy Broidrick to its Board of Directors

CARLSBAD, Calif., Aug. 28, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announced today the addition of pharmaceutical executive Amy Broidrick to the company’s Board of Directors. Ms. Broidrick’s background includes key roles in the successful worldwide launches and…

About the Author

has written 39590 stories on this site.

Copyright © 2010 Business and Corporate News.